erlotinib hydrochloride

Italy

Drugs containing this active substance

  • ERLOTINIB MYLAN

    This medicine is used to treat advanced non-small cell lung cancer in adults. It can be prescribed as initial therapy or if the disease does not change after chemotherapy (if the cancer cells have specific mutations). It can also be used in combination with gemcitabine for metastatic pancreatic cancer.

    Form: tablets, film-coated

    Active substance Dosage
    erlotinib hydrochloride -

    ATC: L01EB02

    Manufacturer: MYLAN S.P.A.

  • TARCEVA

    Tarceva is a medicine used to treat advanced non-small cell lung cancer (as initial therapy or if the disease does not change after chemotherapy) and metastatic stage pancreatic cancer, in combination with gemcitabine.

    Form: tablets, film-coated

    Active substance Dosage
    erlotinib hydrochloride -

    ATC: L01EB02

    Manufacturer: CHEPLAPHARM REGISTRATION GMBH